Table 1.
Baseline characteristics of study patients (FAS)
| Sofpironium (n = 141) | Vehicle (n = 140) | Total (n = 281) | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 35.6 (13.44) | 36.1 (12.44) | 35.8 (12.93) |
| Median | 35.0 | 36.0 | 35.0 |
| Range | 13–72 | 13–72 | 13–72 |
| Sex (%) | |||
| Male | 43 (30.5) | 41 (29.3) | 84 (29.9) |
| Female | 98 (69.5) | 99 (70.7) | 197 (70.1) |
| BMI (kg/m2) | |||
| Mean (SD) | 21.50 (3.292) | 21.84 (3.043) | 21.67 (3.170) |
| Median | 20.96 | 21.36 | 21.22 |
| Range | 14.8–34.2 | 16.0–32.8 | 14.8–34.2 |
| Total gravimetric weight of sweat (mg) | |||
| Mean (SD) | 228.0 (167.10) | 226.3 (128.88) | 227.1 (149.02) |
| Median | 172.0 | 188.5 | 183.0 |
| Range | 105–1083 | 102–778 | 102–1083 |
| HDSS, n (%) | |||
| Grade 3 | 95 (67.4) | 94 (67.1) | 189 (67.3) |
| Grade 4 | 46 (32.6) | 46 (32.9) | 92 (32.7) |
| HDSM‐Ax score | |||
| Mean (SD) | 3.06 (0.514) | 3.04 (0.572) | 3.05 (0.543) |
| Median | 3.09 | 3.00 | 3.09 |
| Range | 2.0–4.0 | 2.0–4.0 | 2.0–4.0 |
| DLQI total score | |||
| Mean (SD) | 11.7 (4.96) | 10.9 (4.42) | 11.3 (4.71) |
| Median | 11.0 | 11.0 | 11.0 |
| Range | 1–26 | 0–23 | 0–26 |
BMI, body mass index; DLQI, Dermatology Life Quality Index; HDSM‐Ax, Hyperhidrosis Disease Severity Measure–Axillary; HDSS, Hyperhidrosis Disease Severity Score; SD, standard deviation.